Get the Stockscreener App
17.35
0.57%
-0.10
After Hours:
17.49
0.14
+0.81%
Innoviva Inc stock is traded at $17.35, with a volume of 534.75K.
It is down -0.57% in the last 24 hours and down -12.68% over the past month.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
See More
Previous Close:
$17.45
Open:
$17.51
24h Volume:
534.75K
Relative Volume:
0.69
Market Cap:
$1.09B
Revenue:
$384.03M
Net Income/Loss:
$38.65M
P/E Ratio:
55.97
EPS:
0.31
Net Cash Flow:
$196.35M
1W Performance:
-0.74%
1M Performance:
-12.68%
6M Performance:
+1.46%
1Y Performance:
-10.98%
1-Day Range:
$17.23
$17.93
1-Week Range:
$17.01
$17.93
52-Week Range:
$16.67
$22.00
Innoviva Inc Stock (INVA) Company Profile
Name
Innoviva Inc
Sector
Industry
Phone
(650) 238-9600
Address
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
Compare INVA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INVA
Innoviva Inc
|
17.35 | 1.10B | 384.03M | 38.65M | 196.35M | 0.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Innoviva Inc Stock (INVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-30-25 | Initiated | Goldman | Sell |
| Aug-11-25 | Initiated | Oppenheimer | Outperform |
| Jul-14-25 | Initiated | H.C. Wainwright | Buy |
| Jul-11-25 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-07-25 | Initiated | Scotiabank | Sector Outperform |
| Jun-18-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-20-22 | Initiated | Goldman | Neutral |
| Nov-20-17 | Initiated | Deutsche Bank | Hold |
View All
Innoviva Inc Stock (INVA) Latest News
Heatmap analysis for Innoviva Inc. and competitorsEarnings Growth Summary & Technical Pattern Based Buy Signals - newser.com
Innoviva (NASDAQ:INVA) Rating Increased to Strong-Buy at Zacks Research - MarketBeat
Technical analysis overview for Innoviva Inc. stockVolume Spike & Comprehensive Market Scan Insights - newser.com
Why Innoviva Inc. (HVE) stock appeals to dividend investors2025 Major Catalysts & Real-Time Price Movement Reports - newser.com
New Strong Buy Stocks for October 10th - sharewise.com
What Fibonacci levels say about Innoviva Inc. rebound2025 Buyback Activity & Reliable Entry Point Alerts - newser.com
Full technical analysis of Innoviva Inc. stock2025 Short Interest & Accurate Buy Signal Notifications - newser.com
What drives Innoviva Inc stock priceMoving Average Crossovers & Build a Smarter Portfolio Right Now - earlytimes.in
Weiss Ratings Reaffirms "Hold (C)" Rating for Innoviva (NASDAQ:INVA) - MarketBeat
QRG Capital Management Inc. Has $2.26 Million Stake in Innoviva, Inc. $INVA - MarketBeat
Innoviva Specialty Therapeutics to Deliver Six Presentations from its Infectious Diseases and Critical Care Portfolio at IDWeek 2025 - BioSpace
Innoviva Specialty Therapeutics to Deliver Six Presentations from its Infectious Diseases and Critic - PharmiWeb.com
Are Investors Undervaluing Innoviva (INVA) Right Now? - sharewise.com
Using Bollinger Bands to evaluate Innoviva Inc.Market Trend Summary & Daily Technical Forecast Reports - newser.com
Is now a turning point for Innoviva Inc.July 2025 Highlights & Smart Swing Trading Alerts - newser.com
Why Innoviva Inc. stock appeals to dividend seekersJuly 2025 Reactions & Free Reliable Trade Execution Plans - newser.com
Applying chart zones and confluence areas to Innoviva Inc.Global Markets & Reliable Intraday Trade Plans - newser.com
How to interpret RSI for Innoviva Inc. stock2025 Breakouts & Breakdowns & Real-Time Market Sentiment Alerts - newser.com
Will earnings trigger a reversal in Innoviva Inc.Weekly Risk Summary & Weekly Momentum Picks - newser.com
Is this a good reentry point in Innoviva Inc.Insider Selling & Verified Swing Trading Watchlist - newser.com
Innoviva (NASDAQ:INVA) Stock Rating Lowered by Wall Street Zen - Defense World
Innoviva (NASDAQ:INVA) Lowered to Buy Rating by Wall Street Zen - MarketBeat
Brokerages Set Innoviva, Inc. (NASDAQ:INVA) PT at $37.60 - Defense World
Order flow analysis tools used on Innoviva Inc.Portfolio Value Summary & Stepwise Trade Execution Plans - newser.com
Innoviva (NASDAQ:INVA) Research Coverage Started at The Goldman Sachs Group - Defense World
Is Innoviva Inc. showing signs of accumulationQuarterly Profit Review & Community Driven Trade Alerts - newser.com
What Does Technical Analysis Say About Star Delta Transformers Limited StockInflation Impact on Stocks & Market Volatility Strategies - earlytimes.in
Innoviva (NASDAQ:INVA) Coverage Initiated at The Goldman Sachs Group - MarketBeat
What analysts say about Innoviva Inc stockSmall Cap Stock Opportunities & Achieve Explosive Results - earlytimes.in
Multi factor analysis applied to Innoviva Inc.2025 Major Catalysts & Long Hold Capital Preservation Plans - newser.com
Goldman Sachs Initiates Coverage of Innoviva (INVA) with Sell Recommendation - Nasdaq
Innoviva (NASDAQ:INVA) Shares Gap DownWhat's Next? - MarketBeat
Innoviva, Inc. (NASDAQ:INVA) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Voya Investment Management LLC Has $271,000 Stock Position in Innoviva, Inc. $INVA - Defense World
GAMMA Investing LLC Grows Holdings in Innoviva, Inc. $INVA - Defense World
Innoviva Inc Stock (INVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Innoviva Inc Stock (INVA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| DENNER ALEXANDER J | 10% Owner |
Mar 05 '25 |
Sale |
17.63 |
270,374 |
4,766,126 |
6,855,451 |
| DENNER ALEXANDER J | 10% Owner |
Mar 04 '25 |
Sale |
17.63 |
151,175 |
2,665,079 |
7,125,825 |
5.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):